Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
RWWithdrawal of registration statement filed under the Securities ActSep 5, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 20, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 20, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 16, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 14, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 14, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 14, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 14, 2007View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionAug 9, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 9, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventAug 7, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 6, 2007View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJul 19, 2007View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJul 9, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJul 3, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 27, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 21, 2007View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Jun 21, 2007View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsJun 15, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 12, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 12, 2007View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJun 12, 2007View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jun 12, 2007View HTMLDownload DOCDownload PDF
4/AAmendment to a previously filed 4Jun 12, 2007View HTMLDownload DOCDownload PDF
SC 13G/AAmendment to a previously filed SC 13GJun 11, 2007View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-98

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information